Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
2.76
0.24 (9.52%)
At close: Sep 05, 2025, 3:59 PM
2.73
-1.09%
After-hours: Sep 05, 2025, 05:53 PM EDT
Editas Medicine Revenue
Editas Medicine reported an annual revenue of $32.31M, reflecting a -58.64% growth. For the quarter ending June 30, 2025, Editas Medicine generated $3.58M in revenue.
Revenue (ttm)
32.31M
Revenue Growth
-58.64%
Price / Sales Ratio
3.24
Revenue / Employee
131.36K
Employees
246
Market Cap
248.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 32.31M | -58.64% |
| Dec 31, 2023 | 78.12M | +296.32% |
| Dec 31, 2022 | 19.71M | -22.83% |
| Dec 31, 2021 | 25.54M | -71.85% |
| Dec 31, 2020 | 90.73M | +341.93% |
| Dec 31, 2019 | 20.53M | -35.71% |
| Dec 31, 2018 | 31.94M | +132.64% |
| Dec 31, 2017 | 13.73M | +126.80% |
| Dec 31, 2016 | 6.05M | +271.58% |
| Dec 31, 2015 | 1.63M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |